Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TWST
TWIST BIOSCIENCE CORPORATION
NASDAQ
$141.38
▼ DOWN 7.66% (-11.72)

KEY STATISTICS

Market Cap$8.80 B
52w High$155.44
52w Low$23.30
Dividend Yield—
Frequency—
P/E-63.68
Volume1.38M
Shares Out.62.27M

COMPANY

LEADERSHIP

Emily Marine Leproust
CHIEF EXECUTIVE
Emily Marine Leproust

COMPENSATION 2026

Salary$720,000
Stock Awards$11,998,134
Incentive Plan Pay$932,918
All Other Comp.$130,518
Total$13,781,570

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 31, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
979

PRICE TARGET

Target High$120.00
Target Low$89.00
Target Median$107.00
Target Consensus$104.67

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.$123.50M
NOV
13
FRI

PRICE

$141.38 ▼ DOWN 7.66% (−$11.72)
$144$148$1529:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM141.38

About Twist Bioscience Corporation

https://www.twistbioscience.com ↗

Twist Bioscience, founded in 2013 and based in South San Francisco, manufactures synthetic DNA products and tools for biotech and drug discovery, leveraging a silicon chip-based DNA synthesis platform through various collaborations.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT TWIST BIOSCIENCE CORPORATION IS KNOWN FOR

Twist Exome 2.0 Panel
Twist Exome 2.0 Panel

The Twist Exome 2.0 Panel is a high-uniformity NGS target enrichment kit for whole exome sequencing, enabling efficient, comprehensive, and cost-effective analysis of protein-coding and relevant non-coding regions for genetic research and disease ...

COMPETITORS

COMPETITOR
A COMPARE
DHR COMPARE
ILMN COMPARE
QGEN COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ4-2025Q1-2026Q2-2026Q3-2026
Ngs Tools$53.03M $52.64M ▼$57.44M ▲$61.8M ▲
Antibody Discovery$6.44M $51.06M ▲$53.27M ▲$56.57M ▲
Synthetic Genes$31.21M — — —
Oligo Pools$5M — — —
Dna And Biopharma Libraries$3.32M — — —

Revenue by Geography

MapREGIONQ4-2025Q1-2026Q2-2026Q3-2026
Americas$57.3M $58.38M ▲$64.31M ▲$77.26M ▲
EMEA$34.55M $38.37M ▲$37.35M ▼$33.62M ▼
Asia Pacific$7.16M $6.95M ▼$9.06M ▲$7.5M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
208
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.01% · 1.9M
ARKK
3.95% · 1.7M
XSU.TO
0.30% · 1.6M
XBI
2.01% · 1.6M
SCHA
0.21% · 310.6K
PSC
0.96% · 175.2K
FESM
0.39% · 168.7K
FTXH
1.31% · 98.1K
TSME
1.51% · 88.8K
FRTY
7.13% · 75.3K
DFAS
0.07% · 71.3K
DOCG.L
3.30% · 71.0K
XRSG.L
0.31% · 64.1K
JTEK
0.19% · 61.5K
LABU
1.37% · 56.8K
PRFZ
0.22% · 45.2K
GNOM
6.43% · 41.9K
HAPS
2.56% · 29.7K
JSML
0.97% · 24.4K
TMAT
1.06% · 23.5K
TTEQ
0.76% · 22.5K
LFSC
2.06% · 18.4K
WBIO.L
7.57% · 17.0K
HTEC
3.30% · 16.9K
HY
HYP
2.63% · 12.4K
GSSC
0.15% · 11.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
94.75%
HOLDERS
439
TOP 12 OF 439 · RANKED BY POSITION SIZE
Ark Investment Management LLC
7.6M sh · $239.79M
Artisan Partners Limited Partnership
6.4M sh · $180.4M
Blackrock, Inc.
6.2M sh · $173.86M
William Blair Investment Management, LLC
6.0M sh · $188.87M
Vanguard Group Inc
5.8M sh · $183.22M
Blackrock Inc.
5.4M sh · $267.28M
Edgepoint Investment Group Inc.
5.4M sh · $255.78M
Fmr LLC
4.7M sh · $483.85M
State Street Corp
3.7M sh · $174.43M
Price T Rowe Associates Inc /Md/
3.6M sh · $373.93M
Invesco Ltd.
2.2M sh · $103.21M
Farallon Capital Management LLC
2.1M sh · $219.79M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Dwight Evans
Dwight Evans
Sale (Full)
2022-03-30

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Leproust Emily M.
Sale · 1.1K shares
2026-08-25
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Leproust Emily M.
Sale · 12.6K shares
2026-08-25
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Leproust Emily M.
Sale · 12.2K shares
2026-08-25
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Leproust Emily M.
Sale · 6.4K shares
2026-08-25

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OVERWEIGHT 2
OUTPERFORM 2
IN LINE 1
8 GRADES IN THE LAST 12 MONTHS
Piper Sandler OVERWEIGHT Baird OUTPERFORM Canaccord Genuity BUY Evercore ISI Group IN LINE Guggenheim BUY Barclays OVERWEIGHT TD Cowen BUY Leerink Partners OUTPERFORM

SECTORS PEERS

PEERPRICE
EWTX$42.76COMPARE
QURE$48.72COMPARE
GPCR$47.37COMPARE
VRDN$23.08COMPARE
GRDN$37.06COMPARE
MESO$17.44COMPARE
CLOV$4.23COMPARE
PRCT$20.83COMPARE